Highbridge Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-54,066
Closed -$3.66M 456
2018
Q3
$3.66M Buy
+54,066
New +$3.44M 0.09% 252
2018
Q2
Sell
-112,678
Closed -$6.36M 1180
2018
Q1
$5.86M Sell
112,678
-230,622
-67% -$12.5M 0.09% 259
2017
Q4
$18.4M Buy
343,300
+96,140
+39% +$5.33M 0.33% 59
2017
Q3
$15.1M Buy
247,160
+224,022
+968% +$13.6M 0.23% 118
2017
Q2
$1.42M Sell
23,138
-278,647
-92% -$17M 0.02% 498
2017
Q1
$18.3M Buy
301,785
+274,374
+1,001% +$16.6M 0.27% 102
2016
Q4
$1.54M Sell
27,411
-161,229
-85% -$9.44M 0.03% 435
2016
Q3
$11.2M Buy
188,640
+172,808
+1,092% +$10.1M 0.18% 137
2016
Q2
$870K Sell
15,832
-1,248
-7% -$66.4K 0.01% 652
2016
Q1
$862K Sell
17,080
-246,262
-94% -$12.1M 0.01% 782
2015
Q4
$13.3M Sell
263,342
-14,212
-5% -$717K 0.2% 134
2015
Q3
$13.1M Sell
277,554
-990,323
-78% -$52.6M 0.2% 137
2015
Q2
$68.9M Buy
1,267,877
+547,617
+76% +$30.7M 0.87% 11
2015
Q1
$39.5M Sell
720,260
-493,584
-41% -$27.9M 0.54% 40
2014
Q4
$65.8M Buy
1,213,844
+240,042
+25% +$13.4M 0.84% 13
2014
Q3
$55.1M Sell
973,802
-80,408
-8% -$4.52M 0.73% 25
2014
Q2
$58.2M Buy
1,054,210
+18,871
+2% +$1.03M 0.71% 14
2014
Q1
$56.1M Buy
1,035,339
+362,727
+54% +$18.8M 0.71% 20
2013
Q4
$32.1M Sell
672,612
-166,071
-20% -$7.59M 0.38% 89
2013
Q3
$38.1M Buy
838,683
+670,878
+400% +$30.6M 0.4% 60
2013
Q2
$7.44M Buy
+167,805
New +$7.49M 0.07% 267

Other funds holding MRK

Highbridge Capital Management's MRK Position: Q4 2018 in Review

Highbridge Capital Management sold out of Merck (MRK) in Q4 2018, closing a stake of 54,066 shares — an estimated $3.66M sold.

Highbridge Capital Management first reported a position in MRK in Q2 2013 and held it in 21 quarters. The position peaked at $68.9M in Q2 2015. 2,250 funds tracked by Wall St. Rank hold MRK as of Q4 2018.

  • Highbridge Capital Management reported no remaining Merck position as of Q4 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 54,066 Merck shares in Q4 2018, an estimated $3.66M.
  • Highbridge Capital Management first reported a position in Merck in Q2 2013 and held it in 21 quarters.
  • Highbridge Capital Management's Merck position peaked at $68.9M in Q2 2015.
  • 2,250 funds tracked by Wall St. Rank held Merck as of Q4 2018.

Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.